Humatica Sponsors RealDeals UK Mid-market Conference 2014

ndetails
Over 300 UK private equity investors and experts convened at the prestigious Landmark Hotel in central London. They discussed a range of topics fundamental to the future of mid-market investing in the UK. Humatica, as one of a selected few sponsors, contributed to the dialogue on successful investing in the sector. Participants agreed that culture and management effectiveness will play a more important role in generating superior financial returns in the future. Oddly, they also agreed that the focus of effort during due diligence and deal making is however currently on other areas like market and financial due diligence, rather than understanding the way that the organisation works. Participants agreed that this focus will shift further in the future.

Related News

Humatica recognized for Best Organizational Due Diligence Solution 2024
20 Feb, 2024 By Humatica

Humatica recognized for Best Organizational Due Diligence Solution 2024

Humatica was recognized for having the Best Organizational Due Diligence Solution by Private Equity Wire in their 2024 European Awards. The award was based on…

Read more arrowicon
Humatica recognized as Best Specialist Private Equity Consulting Firm 2023
23 Nov, 2023 By Humatica

Humatica recognized as Best Specialist Private Equity Consulting Firm 2023

Wealth & Finance International Magazine has announced the winners of this year’s Management Consulting Awards. For the second year running, the Management Consulting Awards looks…

Read more arrowicon
Humatica advises Freshstream on its investment in Project Better Energy
09 Nov, 2023 By Humatica

Humatica advises Freshstream on its investment in Project Better Energy

Humatica advises Freshstream on their investment on Project Better Energy, one of the leading players in the domestic renewable energy sector in the UK  Humatica, the…

Read more arrowicon

Subscribe to our Monthly Newsletter and other News Updates

Receive our news and valuable perspectives on organizational effectiveness each month.